Unsplash by @Pawel_czerwinski, P. Czerwinski

An Interesting Surprise in FDA’s New Policy Guidance Doc on Buprenorphine Treatment for Opioid Use Disorder (OUD)

Buried inside are surprising assertions of fact none of the money players will admit out loud

It was with trepidation that I opened the email link to the document from FDA titled FDA in Brief: FDA finalizes new…